CLINICAL TRIAL OPTIMIZATION
Powering the Acceleration of Research to Transform Patient Outcomes
Iterative Health empowers community clinical research sites and clinical trial sponsors to expand and accelerate patients’ access to novel therapeutics.
Where Sites Drive SuccessLet's Connect
Empowering Sites to Accelerate Trial Success
The Iterative Health Site Network is premier global clinical research network focused accelerating the path to market for gastrointestinal (GI) and hepatology novel therapies. Our focus is on driving the success and growth of our partner sites by empowering them with tech-enabled services. Through partnerships with leading sponsors, we maintain a robust study pipeline while continuously innovating the future of GI clinical research with our dedicated in-house R&D team.
High-Performing Sites Exceed Industry Benchmarks
Our rapidly expanding network of high-performing clinical research sites is on track to become the global leader in GI and Hepatology research, trusted by sponsors to accelerate bringing novel therapies to market.
2X faster site activation
Compared to industry benchmarks
2X speed to 1st patient screened
Compared to industry benchmarks
>4X patient enrollments
Average site performance on IBD studies compared to industry benchmarks
LATEST NEWSRead the Article
Strengthening Research Sites, Accelerating Trial Success
In International Clinical Trials spring edition, our Chief Product Officer Dana Feuchtbaum discusses the challenges research sites face, and what it takes to build sustainable, high-performing operations that support innovation in clinical trials.
Experience and Expertise for GI & Hepatology Trials
Our specialized teams of life science and clinical operations professionals lead strategic partnerships with 25+ leading sponsors across the Biotechnology, Pharmaceutical, and Contract Research Organization (CRO) sectors.
We actively identify and source new clinical trials, manage negotiations, provide feasibility and site selection support, and ensure seamless communication between sites and sponsors, driving efficiency and success at every stage.
Clinical research categories we serve:
• Gastrointestinal: IBD, EoE, Celiac, GERD
• Hepatology: NASH, MASH, PBC, PSC
• Vaccines and Infectious Diseases
• Obesity
Who We Serve
Empowered Sites Accelerate Trial Success
We empower growing, profitable research sites
We enable our sites to perform as top 1% and supply backbone for sustainable growth through tech-enabled services and a team of GI clinical research experts.
- Offer robust pipeline of clinical trials from strategic relationships with 25+ sponsors
- Empower sites with end-to-end services and innovative technology optimizing research operations
- Ongoing support from a team of 30+ Clinical Research Professionals with deep expertise in GI clinical research operations
We partner with clinical trial sponsors to accelerate bringing novel therapies to market
We offer the leading network of GI & Hepatology clinical research sites to enable sponsors to accelerate site selection, activation and exceed trial recruitment goals – ushering new treatments to market faster.
- Growing network of 70+ clinical research sites, primarily in community practice
- Specialized in Phase II – IV trials across multiple GI & Hepatology diseases
- Industry-leading performance on time to site activation and increased patient randomizations
Hear from our Leaders
Learn more about our innovative approach to GI & Hepatology clinical research from our Executives who oversee the teams responsible for sponsor partnerships, site operations, and technology development.
Let’s Connect
Discover how we can partner together to elevate GI & Hepatology clinical research.